Clinical Trial Update: Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating chidamide, dinutuximab beta, irinotecan, and temozolomide for refractory/relapsed neuroblastoma in children; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Chidamide (chidamide)
• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)
• dinutuximab beta (dinutuximab beta)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Neuroblastoma (NB), Neuroblastoma in Children | Phase 2 | Status: NOT_YET_RECRUITING